File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cell based vaccination using transplantation of iPSC-derived memory B cells

TitleCell based vaccination using transplantation of iPSC-derived memory B cells
Authors
Li, JGao, GDYuan, TF
KeywordsAutism
Autoimmune disease
Induced pluripotent stem cells
Memory B cells
Transplantation
Vaccination
Vaccine
Issue Date2009
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine
Citation
Vaccine, 2009, v. 27 n. 42, p. 5728-5729 How to Cite?
DOI: http://dx.doi.org/10.1016/j.vaccine.2009.07.091
AbstractThe recently developed induced pluripotent stem cell (iPSC) technique provides new direction for vaccination: somatic cells can be induced into iPSCs and expanded, then the cells are genetically or chemically promoted to a immune cell fate, followed with in vitro antigen presenting and processing processes to produce memory B cells that can secret functional antibodies to different pathogens; finally these cells are transplanted back to human.
Persistent Identifierhttp://hdl.handle.net/10722/161603
ISSN
0264-410X
2021 Impact Factor: 4.169
2020 SCImago Journal Rankings: 1.585
ISI Accession Number ID
WOS:000270469900002

 

DC FieldValueLanguage
dc.contributor.authorLi, J-
dc.contributor.authorGao, GD-
dc.contributor.authorYuan, TF-
dc.date.accessioned2012-09-03T08:43:54Z-
dc.date.available2012-09-03T08:43:54Z-
dc.date.issued2009-
dc.identifier.citationVaccine, 2009, v. 27 n. 42, p. 5728-5729-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10722/161603-
dc.description.abstractThe recently developed induced pluripotent stem cell (iPSC) technique provides new direction for vaccination: somatic cells can be induced into iPSCs and expanded, then the cells are genetically or chemically promoted to a immune cell fate, followed with in vitro antigen presenting and processing processes to produce memory B cells that can secret functional antibodies to different pathogens; finally these cells are transplanted back to human.-
dc.languageeng-
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine-
dc.relation.ispartofVaccine-
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in Vaccine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Vaccine, [VOL 27, ISSUE 42, 2009] DOI 10.1016/j.vaccine.2009.07.091-
dc.subjectAutism-
dc.subjectAutoimmune disease-
dc.subjectInduced pluripotent stem cells-
dc.subjectMemory B cells-
dc.subjectTransplantation-
dc.subjectVaccination-
dc.subjectVaccine-
dc.subject.meshB-Lymphocytes - immunology-
dc.subject.meshImmunologic Memory-
dc.subject.meshPluripotent Stem Cells - immunology-
dc.subject.meshStem Cell Transplantation-
dc.subject.meshVaccination - methods-
dc.titleCell based vaccination using transplantation of iPSC-derived memory B cellsen_US
dc.typeArticleen_US
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.vaccine.2009.07.091-
dc.identifier.pmid19682618-
dc.identifier.scopuseid_2-s2.0-69749084873-
dc.identifier.hkuros167801-
dc.identifier.volume27-
dc.identifier.issue42-
dc.identifier.spage5728-
dc.identifier.epage5729-
dc.identifier.isiWOS:000270469900002-
dc.publisher.placeUnited Kingdom-
dc.identifier.citeulike5442326-
dc.identifier.issnl0264-410X-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats